TIL stock icon

Instil Bio
TIL

$13.23
2.07%

Market Cap: 86M

 

About: Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Employees: 49

0
Funds holding %
of 6,702 funds
0
Analysts bullish %
of 7 analysts
News positive %

Fund manager confidence

Based on 2024 Q1 SEC filings by fund managers ($100M+ AUM)

100% more funds holding in top 10

Funds holding in top 10: 2 [Q4 2023] → 4 (+2) [Q1 2024]

48% more capital invested

Capital invested by funds: $31M [Q4 2023] → $45.9M (+$14.9M) [Q1 2024]

25% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 4

3% more funds holding

Funds holding: 30 [Q4 2023] → 31 (+1) [Q1 2024]

2.83% more ownership

Funds ownership: 62.52% [Q4 2023] → 65.35% (+2.83%) [Q1 2024]

62% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 13

Research analyst outlook

7 Wall Street Analysts provided 1 year price forecasts over the past 6 months

Low target
$11
17%
downside
Avg. target
$29
121%
upside
High target
$54
308%
upside

7 analyst ratings

positive
86%
neutral
14%
negative
0%
HC Wainwright & Co.
Mitchell Kapoor
36%upside
$18
Buy
Reiterated
13 May 2024
Baird
Jack Allen
142%upside
$32
Outperform
Maintained
13 May 2024
Jefferies
Kelly Shi
17%downside
$11
Hold
Downgraded
12 Apr 2024
HC Wainwright & Co.
Mitchell Kapoor
36%upside
$18
Buy
Reiterated
25 Mar 2024
HC Wainwright & Co.
Mitchell Kapoor
36%upside
$18
Buy
Maintained
22 Jan 2024

Financial journalist opinion